Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Krka, d. d.

Capitalization 7.01B 8.16B 6.33B 6.06B 11.08B 749B 11.43B 74.6B 29.87B 359B 30.62B 29.97B 1,286B P/E ratio 2025 *
18.7x
P/E ratio 2026 * 17.5x
Enterprise value 6.5B 7.57B 5.88B 5.63B 10.28B 695B 10.6B 69.21B 27.72B 333B 28.41B 27.81B 1,194B EV / Sales 2025 *
3.2x
EV / Sales 2026 * 3.02x
Free-Float
70.67%
Yield 2025 *
3.59%
Yield 2026 * 3.92%
1 day+0.44%
1 week+6.48%
Current month-4.17%
1 month-1.29%
3 months+15.00%
6 months+5.99%
Current year+13.30%
1 week 220
Extreme 220
233
1 month 210
Extreme 210
251
Current year 202
Extreme 202
251
1 year 150.5
Extreme 150.5
251
3 years 100
Extreme 100
251
5 years 80
Extreme 80
251
10 years 48.01
Extreme 48.01
251
Manager TitleAgeSince
Chief Executive Officer 70 31/12/2004
Director of Finance/CFO - 31/12/1996
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 31/12/2008
Director/Board Member 59 31/12/2004
Director/Board Member 58 31/12/2004
Change 5d. change 1-year change 3-years change Capi.($)
+0.44%+6.48%+36.50%+116.98% 8.16B
+0.72%+4.19%+13.30%+91.08% 47.36B
+6.77%+7.35%+47.21%+169.11% 34.11B
-1.53%+2.65%+298.35%+1,435.71% 12.47B
-0.30%-1.64%-9.11%+50.87% 11.73B
-0.15%+1.64%+3.14%+94.09% 10.11B
-0.59%+12.02%+79.93%+56.17% 8.76B
-0.91%-4.02%+39.12%-16.24% 7.18B
+2.11%+7.04%+61.98%+430.20% 6.84B
+0.09%+0.52%+13.26%+59.18% 6.46B
Average +0.64%+1.62%+58.37%+248.72% 15.32B
Weighted average by Cap. +1.61%+1.76%+50.10%+223.21%

Financials

2025 *2026 *
Net sales 2.03B 2.37B 1.84B 1.76B 3.21B 217B 3.31B 21.64B 8.67B 104B 8.88B 8.7B 373B 2.13B 2.48B 1.92B 1.84B 3.36B 228B 3.47B 22.65B 9.07B 109B 9.3B 9.1B 391B
Net income 389M 453M 352M 337M 615M 41.62B 634M 4.14B 1.66B 19.95B 1.7B 1.66B 71.44B 405M 472M 366M 350M 640M 43.31B 660M 4.31B 1.73B 20.76B 1.77B 1.73B 74.34B
Net Debt -506M -589M -457M -438M -799M -54.08B -824M -5.38B -2.16B -25.93B -2.21B -2.16B -92.83B -582M -678M -526M -504M -920M -62.24B -949M -6.2B -2.48B -29.84B -2.54B -2.49B -107B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,107
Date Price Change Volume
10/03/26 230.00 +0.44% 4,972
09/03/26 229.00 -0.43% 3,676
06/03/26 230.00 -0.86% 7,888
05/03/26 232.00 +1.31% 8,474
04/03/26 229.00 +6.02% 9,286
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
230.00EUR
Average target price
204.23EUR
Spread / Average Target
-11.20%

Annual profits - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW